Similarly, in NSCLC, while spatial transcriptomics can delineate the distribution patterns of TAMs and correlate them with clinical prognosis, heterogeneity in the expression of genes such as Colony Stimulating Factor 1 Receptor (CSF1R) indicates functional diversity within TAM subsets. The gene discussed is CSF1R; the disease is non-small cell lung carcinoma.